21st August 2018: A new chapter in the provision of advanced cancer care in the North-East of England has started with the official opening of the Rutherford Cancer Centre North East.
8th August 2018: The provision of advanced cancer treatment in the South of England passed a key milestone today with the arrival of the first high energy proton beam therapy system in the region.
7th August 2018: The first patient to be treated with high energy proton beam therapy for breast cancer in the UK commenced treatment this week at the Rutherford Cancer Centre South Wales.
11th April 2018: Proton Partners International announced today it has treated the first patient in the UK with high energy proton beam therapy.
20th March 2018: Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
12th March 2018: IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International, to install three Proteus®ONE* compact proton therapy solutions across the UK.
7th March 2018: Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
22nd February 2018: Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
6th February 2018: The first proton beam therapy system to be installed in the North-East of England was delivered today by Proton Partners International Ltd.
The UK needs to take a ‘giant leap of faith’ in cancer care if it is to avoid falling behind in the development of innovative treatments.
Professor Karol Sikora, medical director of Proton Partners International and a former former head of the World Health Organisation’s cancer programme, said World Cancer Day (today) is a poignant moment for those involved in tackling cancer to make an honest ‘assessement’ of the progress made.
He said: “World Cancer Day has embraced the slogan WeCan ICan which is a wonderfully positive affirmation of what we believe we can achieve in treating cancer. We have brilliant scientists, world-class oncologists and tremendous nurses all passionate in doing their utmost for patients.
“However, we must also be honest and acknowledge that the UK still has to raise its game and take a leap of faith with the treatments that are going to make a difference.
“I, too, am passionate and believe that proton beam therapy can transform cancer care in the UK.
“There are more than 150,000 cancer patients in the UK every year, who are treated with radiation therapy and at least 10% of these patients could be better treated with proton beam therapy. This is a key debate over the supply and demand for proton beam therapy.
“The range of published estimates for the utilisation of protons in radical radiotherapy ranges from 1% to 20% in the US. Recent policy studies from several European countries indicate a 10-15% utilisation of protons in patients treated with radical radiotherapy and this is now the basis of health department strategic planning in Holland, Germany, France, Italy and Scandinavia.
“Estimates would suggest 10-20 proton beam therapy treatment rooms would be required for Britain and would ensure that 10% of patients currently receiving radical radiotherapy would receive protons. It is clear from this that unless we as a country embrace change wholeheartedly, the overall quality of British radiotherapy will fall below European levels by 2020.
“The UK has been left behind in the provision of proton beam therapy treatment centres and I am delighted and proud that is now changing with both private providers and the NHS starting to build clinics.
“As we know, protons deliver the same damage to cancer cells as radiotherapy; however, they can be controlled to stop at a defined point in the body. Protons are not a panacea but they offer excellent treatments for a range of hard tumours and have proved very effective in treating children. The provision of the right facilities are a must so that we as a nation no longer have to send patients to the USA for treatment.”
Proton Partners International has already completed its first proton beam therapy centre in Newport, South Wales and is building a number of oncology centres across the UK named The Rutherford Cancer Centres. The other centres currently under development in Northumberland, Reading and Liverpool will install the same proton beam therapy system. Locations for a clinic in central London are also being considered.